Inhibition of phosphatidylinositol 3-kinase (PI3K) enzyme and human skin carcinoma cell growth by Combretum apiculatum Sond.
Authors:
- Jacqueline MaphuthaJMJacqueline Maphutha
- Danielle TwilleyDTDanielle Twilley
- Namrita LallNamrita Lall
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in South African Journal of Botany
- Vol. 140, 95-102
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation
This publication has 34 references indexed in Scilit:
- Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosisMolecular Cancer, 2013
- Viability Reagent, PrestoBlue, in Comparison with Other Available Reagents, Utilized in Cytotoxicity and Antimicrobial AssaysInternational Journal of Microbiology, 2013
- Targeting PI3K in Cancer: Any Good News?Frontiers in Oncology, 2013
- Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cellsInternational Journal of Molecular Medicine, 2012
- Selective cytotoxicity of Aniba rosaeodora essential oil towards epidermoid cancer cells through induction of apoptosisMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2011
- The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradationProceedings of the National Academy of Sciences, 2010
- PTEN: New Insights into Its Regulation and Function in Skin CancerJournal of Investigative Dermatology, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Mutations induced by ultraviolet lightMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005